Consistent with our previous study (8), the plasma concentration of nesfatin-1 was also increased in the NAFLD rats, and significant correlations with the plasma levels of lipids, insulin, and leptin were observed. The gene discussed is LEP; the disease is metabolic dysfunction-associated steatotic liver disease.